| Primary |
| Glaucoma |
47.4% |
| Intraocular Pressure Increased |
20.1% |
| Drug Use For Unknown Indication |
5.4% |
| Open Angle Glaucoma |
4.9% |
| Product Used For Unknown Indication |
4.4% |
| Ocular Hypertension |
2.7% |
| Anterior Chamber Disorder |
2.5% |
| Developmental Glaucoma |
2.0% |
| Cardiac Failure Congestive |
1.5% |
| Osteoporosis |
1.5% |
| Dry Eye |
1.2% |
| Hypertension |
1.2% |
| Surgery |
1.0% |
| Herpes Zoster |
0.7% |
| Hypercholesterolaemia |
0.7% |
| Intraocular Pressure Test Abnormal |
0.7% |
| Accidental Exposure |
0.5% |
| Age-related Macular Degeneration |
0.5% |
| Angle Closure Glaucoma |
0.5% |
| Arthritis |
0.5% |
|
| Intraocular Pressure Increased |
15.0% |
| Visual Impairment |
11.7% |
| Visual Acuity Reduced |
9.2% |
| Vision Blurred |
8.3% |
| Ocular Hyperaemia |
5.8% |
| Deafness |
4.2% |
| Drug Ineffective |
4.2% |
| Eye Haemorrhage |
4.2% |
| Product Substitution Issue |
4.2% |
| Skin Exfoliation |
4.2% |
| Wheezing |
4.2% |
| Corneal Deposits |
3.3% |
| Pneumonia |
3.3% |
| Sick Sinus Syndrome |
3.3% |
| Bradycardia |
2.5% |
| Conjunctivitis Allergic |
2.5% |
| Deafness Unilateral |
2.5% |
| Eye Irritation |
2.5% |
| Glaucoma |
2.5% |
| Lacrimation Increased |
2.5% |
|
| Secondary |
| Glaucoma |
33.3% |
| Open Angle Glaucoma |
8.9% |
| Hypertension |
8.6% |
| Intraocular Pressure Increased |
7.6% |
| Cataract Operation |
5.2% |
| Ocular Hypertension |
4.5% |
| Drug Use For Unknown Indication |
3.9% |
| Thyroid Disorder |
3.9% |
| Product Used For Unknown Indication |
3.7% |
| Postoperative Care |
2.6% |
| Atrial Fibrillation |
2.1% |
| Corneal Epithelium Defect |
2.1% |
| Hypothyroidism |
2.1% |
| Corneal Abscess |
1.9% |
| Intraocular Lens Implant |
1.8% |
| Keratitis Herpetic |
1.8% |
| Ulcerative Keratitis |
1.8% |
| Ill-defined Disorder |
1.6% |
| Keratitis |
1.5% |
| Endophthalmitis |
1.1% |
|
| Corneal Deposits |
17.2% |
| Visual Acuity Reduced |
13.8% |
| Intraocular Pressure Increased |
7.8% |
| Toxic Anterior Segment Syndrome |
6.0% |
| Pneumonia |
5.2% |
| Vision Blurred |
5.2% |
| Visual Impairment |
5.2% |
| Sick Sinus Syndrome |
4.3% |
| Vitreous Haemorrhage |
4.3% |
| Weight Decreased |
4.3% |
| Hypersensitivity |
3.4% |
| Cystoid Macular Oedema |
2.6% |
| Drug Ineffective |
2.6% |
| Eye Pain |
2.6% |
| Hyperkalaemia |
2.6% |
| Ocular Hyperaemia |
2.6% |
| Paraesthesia |
2.6% |
| Post Procedural Complication |
2.6% |
| Prinzmetal Angina |
2.6% |
| Skin Exfoliation |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.0% |
| Drug Use For Unknown Indication |
16.7% |
| Glaucoma |
15.1% |
| Hypertension |
11.5% |
| Diabetes Mellitus |
3.9% |
| Pain |
3.9% |
| Prophylaxis |
2.7% |
| Atrial Fibrillation |
2.7% |
| Osteoporosis |
2.7% |
| Rheumatoid Arthritis |
2.4% |
| Depression |
2.0% |
| Behcet's Syndrome |
1.9% |
| Type 2 Diabetes Mellitus |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Multiple Myeloma |
1.7% |
| Intraocular Pressure Increased |
1.6% |
| Hyperlipidaemia |
1.5% |
| Constipation |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Nausea |
1.4% |
|
| Intraocular Pressure Increased |
8.5% |
| Rash |
8.3% |
| Weight Decreased |
8.0% |
| Vision Blurred |
7.4% |
| Visual Acuity Reduced |
6.6% |
| Vomiting |
6.6% |
| Death |
6.0% |
| Wheezing |
6.0% |
| Tremor |
4.8% |
| Drug Ineffective |
4.6% |
| Renal Failure Acute |
4.3% |
| Pneumonia |
4.0% |
| Mucosal Inflammation |
3.4% |
| Urinary Tract Infection |
3.4% |
| Weight Increased |
3.4% |
| Blood Glucose Increased |
3.1% |
| Ocular Hyperaemia |
3.1% |
| Fatigue |
2.8% |
| Myocardial Infarction |
2.8% |
| Syncope |
2.8% |
|
| Interacting |
| Glaucoma |
50.0% |
| Essential Hypertension |
20.0% |
| Erectile Dysfunction |
10.0% |
| Keratopathy |
10.0% |
| Postoperative Care |
10.0% |
|
| Drug Interaction |
33.3% |
| Memory Impairment |
33.3% |
| Headache |
16.7% |
| Visual Acuity Reduced |
16.7% |
|
